Literature DB >> 25302171

Caring for the breast cancer survivor's health and well-being.

Petra M Casey1, Stephanie S Faubion1, Kathy L MacLaughlin1, Margaret E Long1, Sandhya Pruthi1.   

Abstract

The breast cancer care continuum entails detection, diagnosis, treatment, and survivorship. During this time, focus on the whole woman and medical concerns beyond the breast cancer diagnosis itself is essential. In this comprehensive review, we critically review and evaluate recent evidence regarding several topics pertinent to and specific for the woman living with a prior history of breast cancer. More specifically, we discuss the most recent recommendations for contraceptive options including long-acting reversible contraception and emergency contraception, fertility and pregnancy considerations during and after breast cancer treatment, management of menopausal vasomotors symptoms and vulvovaginal atrophy which often occurs even in young women during treatment for breast cancer. The need to directly query the patient about these concerns is emphasized. Our focus is on non-systemic hormones and non-hormonal options. Our holistic approach to the care of the breast cancer survivor includes such preventive health issues as sexual and bone health,which are important in optimizing quality of life. We also discuss strategies for breast cancer recurrence surveillance in the setting of a prior breast cancer diagnosis. This review is intended for primary care practitioners as well as specialists caring for female breast cancer survivors and includes key points for evidence-based best practice recommendations.

Entities:  

Keywords:  Breast cancer; Breast cancer recurrence; Breast cancer surveillance; Contraception; Osteopenia; Osteoporosis; Sexual health; Vasomotor symptoms; Vulvovaginal atrophy

Year:  2014        PMID: 25302171      PMCID: PMC4129533          DOI: 10.5306/wjco.v5.i4.693

Source DB:  PubMed          Journal:  World J Clin Oncol        ISSN: 2218-4333


  80 in total

1.  Oral contraceptives and the risk of breast cancer.

Authors:  Polly A Marchbanks; Jill A McDonald; Hoyt G Wilson; Suzanne G Folger; Michele G Mandel; Janet R Daling; Leslie Bernstein; Kathleen E Malone; Giske Ursin; Brian L Strom; Sandra A Norman; Phyllis A Wingo; Ronald T Burkman; Jesse A Berlin; Michael S Simon; Robert Spirtas; Linda K Weiss
Journal:  N Engl J Med       Date:  2002-06-27       Impact factor: 91.245

Review 2.  Chemotherapy and fertility.

Authors:  Zeev Blumenfeld
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2012-01-26       Impact factor: 5.237

Review 3.  A review of acupuncture for menopausal problems.

Authors:  Einar Borud; Adrian White
Journal:  Maturitas       Date:  2010-01-08       Impact factor: 4.342

4.  Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women's health across the nation.

Authors:  Ellen B Gold; Alicia Colvin; Nancy Avis; Joyce Bromberger; Gail A Greendale; Lynda Powell; Barbara Sternfeld; Karen Matthews
Journal:  Am J Public Health       Date:  2006-05-30       Impact factor: 9.308

5.  The 2012 hormone therapy position statement of: The North American Menopause Society.

Authors: 
Journal:  Menopause       Date:  2012-03       Impact factor: 2.953

Review 6.  Cancer treatment and survivorship statistics, 2012.

Authors:  Rebecca Siegel; Carol DeSantis; Katherine Virgo; Kevin Stein; Angela Mariotto; Tenbroeck Smith; Dexter Cooper; Ted Gansler; Catherine Lerro; Stacey Fedewa; Chunchieh Lin; Corinne Leach; Rachel Spillers Cannady; Hyunsoon Cho; Steve Scoppa; Mark Hachey; Rebecca Kirch; Ahmedin Jemal; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2012-06-14       Impact factor: 508.702

7.  Randomised controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception. Task Force on Postovulatory Methods of Fertility Regulation.

Authors: 
Journal:  Lancet       Date:  1998-08-08       Impact factor: 79.321

8.  Discontinuing postmenopausal hormone therapy: an observational study of tapering versus quitting cold turkey: is there a difference in recurrence of menopausal symptoms?

Authors:  Sally G Haskell; Bevanne Bean-Mayberry; Kirsha Gordon
Journal:  Menopause       Date:  2009 May-Jun       Impact factor: 2.953

Review 9.  Cancer-treatment-induced bone loss, part 1.

Authors:  Laura Boehnke Michaud; Susan Goodin
Journal:  Am J Health Syst Pharm       Date:  2006-03-01       Impact factor: 2.637

10.  Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial.

Authors:  Jack Cuzick; Ivana Sestak; Michael Baum; Aman Buzdar; Anthony Howell; Mitch Dowsett; John F Forbes
Journal:  Lancet Oncol       Date:  2010-11-17       Impact factor: 41.316

View more
  4 in total

Review 1.  Reproductive health care across the lifecourse of the female cancer patient.

Authors:  Lisa A Rubinsak; Mindy S Christianson; Aletha Akers; Jeanne Carter; Andrew M Kaunitz; Sarah M Temkin
Journal:  Support Care Cancer       Date:  2018-07-26       Impact factor: 3.603

Review 2.  Breast cancer under age 40: a different approach.

Authors:  D Ribnikar; J M Ribeiro; D Pinto; B Sousa; A C Pinto; E Gomes; E C Moser; M J Cardoso; F Cardoso
Journal:  Curr Treat Options Oncol       Date:  2015-04

Review 3.  Contraceptive Strategies in Women With Heart Failure or With Cardiac Transplantation.

Authors:  Anjli Maroo; Johnny Chahine
Journal:  Curr Heart Fail Rep       Date:  2018-06

4.  Evidenced-based practice of decision-making process in oncofertility care among registered nurses: A qualitative study.

Authors:  Ching-Ting Lien; Sheng-Miauh Huang; Yi Hua Chen; Wen-Ting Cheng
Journal:  Nurs Open       Date:  2020-11-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.